Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Mescaline: The forgotten psychedelic

Ian G Campbell, Ioanna A. Vamvakopoulou, Kelly A.d. Narine, Jason R.b. Dyck, David Nutt

Neuropharmacology October 14, 2022 DOI: 10.1016/j.neuropharm.2022.109294 (opens in new tab) via OpenAlex

Summary

AI-generated from the abstract

Mescaline's pharmacological mechanisms resemble those of other classical psychedelics such as psilocybin and LSD. Consumption appears safe, with most intoxications being mild and easily treatable. The substance may offer clinical benefits, including improvements in mental well-being and potential to help overcome alcoholism. This article is part of a special issue on psilocybin research.

Study at a glance

Characteristics Review Peer reviewed
Topics LSD Mescaline Psilocybin Serotonin
Keywords Hallucinogen Psychotomimetic
Citations 97
Key finding Mescaline appears safe and potentially beneficial in clinical settings, with mechanisms similar to other classical psychedelics.

Abstract

The pharmacological mechanisms of mescaline are similar to those of other classical psychedelics, like psilocybin and lysergic acid diethylamide (LSD). Mescaline appears to be safe to consume, with most intoxications being mild and easily treatable. Improvement in mental well-being and its ability to overcome alcoholism render mescaline potentially beneficial in clinical settings. This article is part of the Special Issue on 'Psilocybin Research'.

Explore topics

Comments

No comments yet.

Log in to comment